A carregar...
Hereditary Angioedema Therapy: Kallikrein Inhibition and Bradykinin Receptor Antagonism
Current strategies for the treatment of hereditary angioedema (HAE) include targeted inhibition or antagonism of the contact system, which is dysregulated in HAE patients by a C1 esterase inhibitor deficiency. Ecallantide, a plasma kallikrein inhibitor, and icatibant, a selective bradykinin-2 recept...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
World Allergy Organization
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3666151/ https://ncbi.nlm.nih.gov/pubmed/23282868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/1939-4551-3-S3-S34 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|